Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotype

BACKGROUND: We analyzed the responses to first line treatment and clinical outcomes of metastatic breast cancer patients treated with palliative doxorubicin/cyclophosphamide (AC) according to molecular cancer subtype. METHODS: A retrospective analysis was performed for 110 metastatic breast cancer p...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Yi, Seong Yoon, Ahn, Jin Seok, Uhm, Ji Eun, Lim, Do Hyoung, Ji, Sang Hoon, Jun, Hyun Jung, Kim, Kyoung Ha, Chang, Myung Hee, Park, Min Jae, Cho, Eun Yoon, La Choi, Yoon, Park, Yeon Hee, Im, Young-Hyuck
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: BioMed Central 2010
Θέματα:
Research Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2972282/
https://ncbi.nlm.nih.gov/pubmed/20920367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-527
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια